In-situ breast cancer: the EORTC consensus meeting.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  The Lancet

• Publication date

  1989-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0140-6736(89)90263-8PMID 2567800
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ductal carcinoma in situ (intraductal carcinoma) of the breast.

  1988cited by this paper
• The impact of tumor size and histology on local control after breast-conserving therapy.

  1988cited by this paper
• Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer.

  1988cited by this paper
• Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies.

  1987cited by this paper
• Importance of cellular DNA content in pre‐malignant breast disease and pre‐invasive carcinoma of the female breast

  1987cited by this paper
• Pathologic findings from the national surgical adjuvant breast project (protocol 6) I. Intraductal carcinoma (DCIS)

  1986cited by this paper
• Breast relapse following primary radiation therapy for early breast cancer. II. Detection, pathologic features and prognostic significance.

  1985cited by this paper

• Interobserver agreement and histologic analysis of atypical ductal hyperplasia bordering on ductal carcinoma in situ: A multi-institutional study.

  2025cites this paper
• Open Access

  2021cites this paper
• Mechanostimulation of integrin αvβ6 and fibronectin in DCIS myoepithelial cells

  2018cites this paper
• Ductal Carcinoma In Situ : Comparison of Mammography , Ultrasonography , and MRI in the Evaluation of Disease Extent

  2016cites this paper
• Impact of the presence and quantity of ductal carcinoma in situ component on the outcome of invasive breast cancer.

  2015cites this paper
• STEROID RECEPTOR EXPRESSION IN DIAGNOSIS AND PROGNOSIS OF LIBYAN BREAST CANCER by

  2012cites this paper
• Our orientation regarding the ductal carcinoma in situ of the breast.

  2012cites this paper
• Application of morphometry, static DNA ploidy analysis, and steroid receptor expression in diagnosis and prognosis of Libyan breast cancer

  2012cites this paper
• Malignant disease of the breast

  2011cites this paper
• Aus der Forschungsgruppe Chirurgische Onkologie am Experimental and Clinical Research Center des Max-Delbrück-Centrums für Molekulare Medizin und der Medizinischen Fakultät Charité – Universitätsmedizin Berlin

  2010cites this paper
• MR imaging of ductal carcinoma in situ.

  2010cites this paper
• Changes in CpG Islands Promoter Methylation Patterns during Ductal Breast Carcinoma Progression

  2009cites this paper
• Ductal carcinoma in situ of the breast: our experience.

  2009cites this paper
• CARCINOME CANALAIRE IN SITU DU SEIN : PLACE DE L'IMAGERIE

  2008cites this paper
• Sentinel Lymph Node Biopsy in Patients with Breast Cancer

  2008cites this paper
• Nipple discharge: a sign of breast cancer?

  2007cites this paper
• Overdiagnosis and overtreatment of breast cancer: Progression of ductal carcinoma in situ: the pathological perspective

  2006cites this paper
• Ductal carcinoma in situ of the breast

  2006cites this paper
• Trends in the Diagnosis of /n Situ Breast Cancer in the Detroit Metropolitan Area, 1973 to 1987

  2006cites this paper
• Interpretation of the risk associated with the unexpected finding of lobular carcinoma in situ

  2006cites this paper
• [Ductal carcinoma in situ of the breast].

  2006cites this paper
• CpG Island Hypermethylation in Breast Cancer Progression and Metastasis

  2005cites this paper
• Imaging in situ breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography

  2004influential citation
• Metastatic potential of small and minimally invasive breast carcinomas

  2004cites this paper
• Management of in situ and minimally invasive breast carcinoma

  2004cites this paper
• Veränderungen des milchableitenden Systems

  2003cites this paper
• The diagnosis and management of pre-invasive breast disease: Ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH) – current definitions and classification

  2003cites this paper
• Point: sentinel lymph node biopsy is indicated for patients with DCIS.

  2003cites this paper
• Lesions of the Terminal Ducts and Lobules

  2003cites this paper
• Lesions of the Ductal System

  2003cites this paper
• Veränderungen des milchproduzierenden Systems

  2003cites this paper
• Ductal Carcinoma in Situ of the Breast; Diagnostic Assessment and Treatment

  2002cites this paper
• Extent of ductal carcinoma in situ within and surrounding invasive primary breast carcinoma

  2001cites this paper
• Screen detected ductal carcinoma in situ (DCIS): overdiagnosis or an obligate precursor of invasive disease?

  2001cites this paper
• Prospective Comparison of Stereotactic Core Biopsy and Surgical Excision as Diagnostic Procedures for Breast Cancer Patients

  2001cites this paper
• Evidence of Benefit of Screening in Other Cancers

  2001cites this paper
• THE ACCURACY AND EFFECTIVENESS OF ROUTINE POPULATION SCREENING WITH MAMMOGRAPHY, PROSTATE-SPECIFIC ANTIGEN, AND PRENATAL ULTRASOUND

  2001cites this paper
• Relationship between the morphological and biological characteristics of intraductal components accompanying invasive ductal breast carcinoma and patient age

  2000cites this paper
• Ductal carcinoma in situ of the breast: Frequency of biomarkers according to histologic subtype

  1999cites this paper
• [Ductal carcinoma in situ of the breast: role of imaging].

  1998cites this paper
• The fourth EORTC DCIS Consensus meeting (Château Marquette, Heemskerk, The Netherlands, 23-24 January 1998)--conference report.

  1998cites this paper
• Nucleotide Sequence of a Highly Conserved of the Canine p53 Turnour Suppressor Gene

  1997cites this paper
• Nucleotide sequence of a highly conserved region of the canine p53 tumour suppressor gene.

  1997cites this paper
• Factors affecting surgical margin clearance in screen-detected breast cancer and the effect of cavity biopsies on residual disease.

  1997cites this paper
• Ductal carcinoma in situ of the breast--current management.

  1997cites this paper
• [Ultrasound mammography].

  1997cites this paper
• [Standardization of tests for the pathology of the breast].

  1996cites this paper
• Atypical ductal hyperplasia, ductal carcinoma in situ and in situ atypical apocrine proliferations of the breast

  1996cites this paper
• Immunohistochemical detection of oestrogen receptors in ductal carcinoma in situ of the breast.

  1996cites this paper
• Ductal carcinoma in situ: Assessment of necrosis and nuclear morphology and their association with biological markers

  1995cites this paper
• Mammographically detected ductal carcinoma in situ: are we overdiagnosing breast cancer?

  1995cites this paper
• Nucleotide sequence of exons 5 to 9 of the p53 tumour-suppressor gene of the donkey (Equus asinus).

  1995cites this paper
• Response—blunting the counterpoint

  1995cites this paper
• Risk from Benign Breast Disease

  1995cites this paper
• Screening for cancer and pre-cancer.

  1995cites this paper
• Management of ductal carcinoma in situ of the breast.

  1995cites this paper
• Loss of heterozygosity and p53 gene mutations in breast cancer.

  1994cites this paper
• Mammographic appearance of calcifications as a predictor of intraductal carcinoma histologic subtype

  1994cites this paper
• Third meeting of the DCIS Working Party of the EORTC (Fondazione Cini, Isola S. Giorgio, Venezia, 28 February 1994)--Conference report.

  1994cites this paper
• Tumor-suppressor genes in breast cancer progression.

  1994cites this paper
• Diagnosis of ‘early’, ‘minimal’ and impalpable breast carcinoma

  1994cites this paper
• [Lobular carcinoma in situ of the breast].

  1994cites this paper
• Management of in situ and minimally invasive breast carcinoma

  1994cites this paper
• Mammographic follow up: a vital component of breast cancer management.

  1993cites this paper
• Ductal carcinoma in situ of the breast.

  1993cites this paper
• Molecular aspects of early stages of breast cancer progression

  1993cites this paper
• Molecular genetic changes in human breast cancer.

  1993cites this paper
• Molecular genetic changes in human breast cancer.

  1993cites this paper
• Behandlung des Carcinoma in situ

  1993cites this paper
• [Ductal carcinoma in situ of the breast].

  1993cites this paper
• Ductal carcinoma in situ.

  1992cites this paper
• Ductal carcinoma in-situ of the breast; second EORTC consensus meeting.

  1992cites this paper
• Breast carcinoma in situ.

  1992cites this paper
• Ductal carcinoma in situ of the female breast. Short-term results of a prospective nationwide study. The Danish Breast Cancer Cooperative Group.

  1992cites this paper
• Intraductal breast cancer: review of 183 consecutive cases.

  1992cites this paper
• Trends in the surgical treatment of ductal carcinoma in situ of the breast.

  1992cites this paper
• The benefits and risks of mammographic screening for breast cancer.

  1992cites this paper
• The continuing dilemma of lobular carcinoma in situ.

  1992cites this paper
• Trends in the diagnosis of in situ breast cancer in the Detroit metropolitan area, 1973 to 1987

  1992cites this paper
• Routine histoprognostic factors in early-stage breast carcinoma: a review.

  1992cites this paper
• Risk of Infiltrating Breast Cancer Subsequent to Lobular Carcinoma in Situ

  1992cites this paper
• Impact of an Extensive in Situ Component on the Presence of Residual Disease in Screen Detected Breast Cancer

  1991cites this paper
• Risk of invasive cancer in women with lobular carcinoma in situ of the breast.

  1991cites this paper
• Results of treating ductal carcinoma In situ of the breast with conservative surgery and radiation therapy

  1991cites this paper
• Reasons for non-entry of patients with DCIS of the breast into a randomised trial (EORTC 10853).

  1991cites this paper
• Breast cancer: the decision to screen.

  1991cites this paper
• [Recent data provided by fine needle aspiration of the breast].

  1991cites this paper
• Breast Cancer–Biology and Malpractice

  1991cites this paper
• Third variety of in-situ carcinoma of the breast.

  1991cites this paper
• Breast screening and the surgeon.

  1991cites this paper
• DNA ploidy of primary breast cancer and local recurrence after breast-conserving therapy.

  1991cites this paper
• Breast conservation, the problem of treating the excision site effectively: physical criteria for the choice of technique used.

  1991cites this paper
• Breast imaging. A critical aspect of breast conserving treatment

  1990cites this paper
• Intraductal Breast Carcinoma. Review of a Multicenter Series of 350 Cases

  1990cites this paper
• In-situ carcinoma of the breast.

  1990cites this paper
• Early experience with needle localization and biopsy of mammographic lesions.

  1990cites this paper
• What can a woman do about her risk of dying of breast cancer?

  1990cites this paper
• Is radiotherapy as curative as mastectomy for patients with ductal carcinoma in situ?

  1990cites this paper
• Intraductal breast carcinoma. Review of a multicenter series of 350 cases.

  1990cites this paper
• Breast Cancer Screening in Women over Age 50

  1990cites this paper